Buscar | SPORTIVO Network

rohit001 agregó una foto Other
2026-07-17 07:14:55

HER2+ Gastric Cancer Market Advances with Targeted Therapy Innovations and Precision Oncology Developments
According to the latest report published by Data Bridge Market Research, the HER2+ Gastric Cancer Market The global HER2+ Gastric Cancer market was valued at USD 1.32 billion in 2024 and is expected to reach USD 1.86 billion by 2032During the forecast period of 2025 to 2032 the market is sly to grow at a CAGR of 4.44% This global HER2+ Gastric Cancer Market report is a...

0 Commentarios 0 Acciones 492 Views 0 Vista previa

Please log in to like, share and comment!
terrilbuckley275 agregó una foto Other
2026-06-12 13:09:53

Prostate Cancer Treatment Market Trends: Advancements in Targeted Therapy, Radioligand Therapy, and Precision Medicine
The global Prostate Cancer Treatment Market is witnessing significant growth due to the increasing prevalence of prostate cancer, advancements in precision medicine, rising healthcare expenditure, and the growing adoption of innovative treatment approaches. According to The Insight PArtners, the prostate cancer treatment market size is projected to grow from US$ 19.07 billion in 2022 to US$...

0 Commentarios 0 Acciones 317 Views 0 Vista previa

Please log in to like, share and comment!
rishika_2003 agregó una foto Health
2026-03-13 10:16:02

VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology Therapies
According to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...

0 Commentarios 0 Acciones 9K Views 0 Vista previa

Please log in to like, share and comment!
Kumud agregó una foto Health
2026-03-27 12:55:09

Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%
According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...

0 Commentarios 0 Acciones 5K Views 0 Vista previa

Please log in to like, share and comment!
Kumud agregó una foto Health
2026-04-07 12:36:34

Bladder Cancer Market to Reach USD 4.1 Billion by 2031 | CAGR 6.7%
According to a newly published market research report by 24LifeSciences, global bladder cancer market was valued at USD 2.6 billion in 2024 and is projected to reach USD 4.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2025-2031. Bladder cancer remains one of the most prevalent urological malignancies worldwide, with non-muscle invasive...

0 Commentarios 0 Acciones 3K Views 0 Vista previa

Please log in to like, share and comment!
Kumud agregó una foto Health
2026-04-08 12:58:09

Bone Metastasis Therapeutics Market Growth & CAGR 8.3% Forecast
According to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...

0 Commentarios 0 Acciones 2K Views 0 Vista previa

Please log in to like, share and comment!
Kumud agregó una foto Health
2026-04-08 13:01:29

Bone Metastasis Therapeutics Market Growth & CAGR 8.3% Forecast
According to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...

0 Commentarios 0 Acciones 2K Views 0 Vista previa

Please log in to like, share and comment!
rishika_2003 agregó una foto Health
2026-03-13 09:33:39

Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma Therapies
According to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...

1

0 Commentarios 0 Acciones 5K Views 0 Vista previa

Please log in to like, share and comment!
Vanshika agregó una foto Health
2026-05-28 09:01:27

Epidermal Growth Factor Receptor Inhibitor Market Strategic Insights for Leading Companies
The global Epidermal Growth Factor Receptor (EGFR) inhibitor industry is witnessing substantial momentum due to the increasing prevalence of cancer, growing adoption of targeted therapies, and advancements in precision medicine. The Epidermal Growth Factor Receptor Inhibitor Market size is expected to reach US$ 32.14 Billion by 2034 from US$ 15.92 Billion in 2025. The market is estimated to...

0 Commentarios 0 Acciones 697 Views 0 Vista previa

Please log in to like, share and comment!
rishika_2003 agregó una foto Health
2026-03-16 06:30:43

Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology Adoption
According to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...

0 Commentarios 0 Acciones 3K Views 0 Vista previa

Please log in to like, share and comment!
Kumud agregó una foto Health
2026-04-09 09:44:26

Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)
According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...

1

0 Commentarios 0 Acciones 2K Views 0 Vista previa

Please log in to like, share and comment!
Kumud agregó una foto Health
2026-04-09 09:47:12

Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)
According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...

1

0 Commentarios 0 Acciones 2K Views 0 Vista previa

Please log in to like, share and comment!
Vanshika agregó una foto Health
2026-06-01 11:21:37

HDAC Inhibitor Market Outlook Across Oncology and Therapeutic Applications
The global HDAC inhibitor market is gaining significant momentum as the healthcare industry continues to advance targeted therapies for cancer and other complex diseases. Histone deacetylase (HDAC) inhibitors are a class of compounds that regulate gene expression by altering chromatin structure, making them valuable in the treatment of various malignancies and epigenetic disorders. The...

0 Commentarios 0 Acciones 697 Views 0 Vista previa

Please log in to like, share and comment!
Vanshika agregó una foto Health
2026-06-03 12:08:01

Imatinib Drug Market Dynamics and Long-Term Growth Potential
The global imatinib drug market continues to play a crucial role in the oncology sector due to the widespread use of imatinib in targeted cancer therapies. As one of the pioneering tyrosine kinase inhibitors, imatinib has significantly transformed the treatment landscape for specific cancers by offering targeted therapeutic benefits. The drug remains an important treatment option in various...

0 Commentarios 0 Acciones 778 Views 0 Vista previa

Please log in to like, share and comment!

Resultados de la búsqueda